Enjamb Labs is an AI platform that streamlines drug development, clinical research, and regulatory processes for biopharma teams.
Enjamb Labs's investors include Y Combinator, Founders, Inc..
Enjamb Labs is headquartered in San Francisco, United States.
Enjamb Labs is an AI platform that streamlines drug development, clinical research, and regulatory processes for biopharma teams.
Enjamb Labs is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enjamb Labs — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/enjamb-labs. Accessed October 5, 2026.
VCBacked. (2026). Enjamb Labs — Funding & Investors. Retrieved October 5, 2026, from https://www.vcbacked.co/company/enjamb-labs
{{cite web |title=Enjamb Labs — Funding & Investors |url=https://www.vcbacked.co/company/enjamb-labs |website=VCBacked |access-date=October 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated